Overview
Immunotherapy is a treatment strategy that mobilises or modifies the immune system to recognise and eliminate disease, most prominently malignancy. Rather than acting directly on a tumour, it restores or amplifies host immune effector activity, particularly the cytotoxic T-cell response, against transformed or infected cells. The articles gathered here trace its principal mechanistic branches. Checkpoint blockade, exemplified by inhibition of the programmed cell death protein-1 pathway, releases the brakes that tumours exploit to evade T cells and has reshaped melanoma management. Adoptive cell transfer, including chimeric antigen receptor (CAR) T-cell engineering and its convergence with nanotechnology, equips patient-derived lymphocytes with redirected specificity. Combination approaches pair immunotherapy with radiation to convert irradiated tumours into in-situ vaccines, while immunomonitoring through immunoassays and immunogenomic profiling tracks response and resistance across cancer and infectious disease. Related work on oncofoetal antigens such as alpha-fetoprotein illustrates the antigen targets these therapies depend on. Collectively the collection situates immunotherapy as a distinct modality alongside surgery, chemotherapy and radiotherapy, with the capacity for durable remission balanced against immune-related toxicity, variable response rates, and the ongoing challenge of predicting which patients will benefit.
Research published in this journal
11 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Avant Garde Alleviation -Cancer Immunotherapy
Combination of Radiation Therapy and Immunotherapy in the Treatment of Melanoma
Nanotechnology Meets Immunotherapy: CAR-T Cells Technology and Beyond
The Current Immunoassays and Emerging Immunogenomic Approaches for Immunomonitoring Cancer and Infectious Diseases
Alpha-Fetoprotein and its Receptor: More Than Oncofoetal Antigens.
Anti-DPPX-Encephalitis in A Patient with Cerebral Vasculitis and Connective Tissue Disease
Advancements in Cancer Gene Therapy: A Comprehensive Review
Molecular Diagnosis in Clinical Management and Diagnosis of Thyroid Cancer
Blockade of Programmed Cell Death Protein-1 Pathway for the Treatment of Melanoma
How this research is being cited
The 11 articles above have been cited 42 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Nov 2026.
-
2024 · Experimental Dermatology
-
2024 · Experimental Dermatology
-
2024 · WIREs Mechanisms of Disease
-
2024 · Journal of Environmental Pathology, Toxicology and Oncology
-
2023 · Biosensors and Bioelectronics
-
2023 · International Immunopharmacology
-
2023 · WIREs Mechanisms of Disease
-
2023 · International Journal of Pharmaceutical Sciences Review and Research
A sample of recent works citing this journal's research on Immunotherapy, linking to each citing work.